Location: Miami, FL/USA 22.01.2018 – 25.01.2018 apceth’s Senior Management will give a talk and participate in a panel discussion at this conference. Conference Webpage „The world’s only whole-ecosystem partnering event for the cell & gene therapy industry.” (Citation: Conference Webpage)
This phase I/II, first-in-class, first-in-men clinical trial tested safety, tolerability and efficacy of genetically modified mesenchymal stem cells (MSC) in the treatment of advanced, recurrent gastrointestinal cancer. Download publication: Publication_apceth Biopharma_TREAT-ME 1 clinical trial Please note: today apceth Biopharma focuses solely on the CDMO business
apceth Biopharma is proud to announce a new manufacturing partnership with DCPrime. The collaboration involves clinical batch production and the development of a commercial scale manufacturing process of cancer vaccines based on DCPrime’s technology platform DCOne®. The companies also announce that apceth has recently successfully passed an inspection by the District Government of Upper Bavaria and the Paul-Ehrlich-Institute for the manufacturing license for production of DCP-001, DCPrime’s lead program. This will enable DCPrime to enter into a Phase II Proof of Concept study in Acute Myeloid Leukemia. For more information, please consult the full press release: Download Press Release_DCPrime and apceth Biopharma Please note: today apceth Biopharma focuses solely on the CDMO business
Location: Berlin, Germany 06.11.2017 – 08.11.2017 Conference Webpage „BIO-Europe is Europe’s largest life science partnering conference. BIO-Europe’s world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.” (Citation: Conference Webpage)
Location: Heidelberg, Germany 10.10.2017 – 11.10.2017 apceth Representatives will give a talk at this conference. Conference webpage “The EBDC is a two-day meeting that aims to bring a selected group of 120 business development executives from international pharmaceutical corporations and European biotech companies together with representatives from private equity and venture capital companies. As always we will offer a sophisticated line-up of international speakers in four sessions focusing on the newest trends in therapeutic development. The EBCD programme also includes company presentations from innovative biotechs and of course provides conference partnering again.” (Citation: Conference Webpage)
apceth Biopharma GmbH (www.apceth.com), a cell therapy company with a proprietary portfolio of genetically modified mesenchymal stem cell therapeutics for the treatment of inflammatory diseases and cancer, and a successful Contract Development and Manufacturing Organisation (CDMO) for cell and gene therapy products, announced today the appointment of Mr Dusan Kosijer as new Chief Financial Officer, effective immediately. Download Press Release ENG (PDF) Please note: today apceth Biopharma focuses solely on the CDMO business
Location: Martinsried / Munich, Germany 16.05.2017 – 17.05.2017 GMP seminar in organization of Concept Heidelberg and BioM with participation of apceth GMP experts as lecturers. For more information see the seminar webpage!
Location: Berlin, Germany 17.10.2017 – 20.10.2017 • apceth talk • apceth is sponsoring this event Conference webpage The 2017 ESGCT event is organised in collaboration with the German Society for Gene Therapy DG-GT.
Location: Valencia, Spain 27.06.2017 – 28.06.2017 apceth experts will hold two presentations at this conference. Conference webpage “…This conference will cover a broad variety of essential biological information. The aim and scope of this meeting are to present and future developments in Gene and Cell Therapies, as well as the manufacturing and clinical implementation of ATMPs. This meeting has established itself among a distinct circle of international experts, regularly attended by leading representatives coming from government agencies (EMA/CAT, EU Commission, etc.), academia and industry. Over the course of these two days, attendees will gain insights into current approaches by European regulators, and several of the leading industry and academic experts will share their unique perspectives and experiences. …” (Citation from the Conference webpage)
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.